Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on May 7, 2010. The filing details corporate governance actions taken by the Compensation Committee and the Board of Directors, including executive compensation adjustments, equity award grants, and the results of the Annual Meeting of Stockholders.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation and stockholder voting results.
Material Changes and Compensation Actions
Executive Officer Salaries
Effective July 1, 2010, revised annual salaries were approved for the following officers:
- Russell C. Horowitz: $195,000
- Matthew Berk: $175,000
- Ethan Caldwell: $195,000
- Peter Christothoulou: $195,000
Performance Equity Awards
Effective May 11, 2010, stock options and restricted stock units (RSUs) were granted with an exercise price of $4.89 per share. Vesting is contingent on time and specific stock price targets ($7.00, $8.00, or $9.00) over 12, 21, or 30 months.
| Executive Officer | Options (Shares) | RSUs (Shares) |
|---|---|---|
| Russell C. Horowitz | 135,000 | 45,000 |
| Michael Arends | 99,000 | 33,000 |
| Ethan Caldwell | 54,000 | 18,000 |
| Peter Christothoulou | 117,000 | 39,000 |
Standard Stock Option and Restricted Stock Awards
Additional grants were approved effective May 11, 2010, with an exercise price of $4.89 per share. Options vest 25% annually with quarterly vesting thereafter; restricted shares vest 25% annually over four years.
| Executive Officer | Options (Shares) | Restricted Shares |
|---|---|---|
| Russell C. Horowitz | 47,500 | 95,000 |
| Michael Arends | 35,000 | 70,000 |
| Matthew Berk | 15,000 | 30,000 |
| Ethan Caldwell | 22,500 | 45,000 |
| Peter Christothoulou | 37,500 | 75,000 |
Annual Incentive Plan
The Compensation Committee determined to take no action regarding the Annual Incentive Plan for the 2010 fiscal period.
Plan Amendment
The Board approved an amendment to the 2003 Amended and Restated Stock Incentive Plan to explicitly allow for the grant of restricted stock units (RSUs) in addition to options and restricted stock.
Guidance, Outlook, and Risks
The filing contains no financial guidance or outlook. A key contingency noted is the "Change of Control" provision: 100% of unvested awards become immediately vested upon a Change of Control followed by termination without cause, diminution in duties, or the 12-month anniversary of the event, provided applicable stock price targets are met for performance awards.
Annual Meeting Results
Stockholders elected the following directors and ratified KPMG LLP as the independent auditor:
- Directors Elected: Russell C. Horowitz, Dennis Cline, Anne Devereux, Nicolas Hanauer, John Keister, and M. Wayne Wisehart.
- Auditor Ratification: KPMG LLP received 290,834,401 votes for, 1,202,161 against, and 54,301 abstentions.
Investor Verification Checklist
- Verify the specific vesting schedules and stock price targets ($7.00, $8.00, $9.00) for the performance equity awards.
- Confirm the total dilution impact of the 600,000+ new options and restricted shares granted to executives.
- Review the full text of the Executive Officer Stock Option and Restricted Stock Agreements filed as exhibits to understand the precise definitions of "Change of Control" and "Diminution in Duties."
- Monitor the company's stock price relative to the $4.89 exercise price and the $7.00-$9.00 performance targets to assess vesting probability.